These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24834836)

  • 1. Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease.
    Wu CL; Zhao SP; Yu BL
    Biol Rev Camb Philos Soc; 2015 May; 90(2):367-76. PubMed ID: 24834836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The exchangeable apolipoproteins in lipid metabolism and obesity.
    Su X; Peng D
    Clin Chim Acta; 2020 Apr; 503():128-135. PubMed ID: 31981585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of apolipoprotein A5 in obesity and the metabolic syndrome.
    Zheng XY; Zhao SP; Yan H
    Biol Rev Camb Philos Soc; 2013 May; 88(2):490-8. PubMed ID: 23279260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients.
    Wree A; Schlattjan M; Bechmann LP; Claudel T; Sowa JP; Stojakovic T; Scharnagl H; Köfeler H; Baba HA; Gerken G; Feldstein AE; Trauner M; Canbay A
    Metabolism; 2014 Dec; 63(12):1542-52. PubMed ID: 25267016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers.
    Feng Q; Baker SS; Liu W; Arbizu RA; Aljomah G; Khatib M; Nugent CA; Baker RD; Forte TM; Hu Y; Zhu L
    Pathology; 2015 Jun; 47(4):341-8. PubMed ID: 25938357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of apolipoprotein A5 in non-alcoholic fatty liver disease.
    Ress C; Moschen AR; Sausgruber N; Tschoner A; Graziadei I; Weiss H; Schgoer W; Ebenbichler CF; Konrad RJ; Patsch JR; Tilg H; Kaser S
    Gut; 2011 Jul; 60(7):985-91. PubMed ID: 21339203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.
    Su X; Kong Y; Peng DQ
    Lipids Health Dis; 2018 Jul; 17(1):174. PubMed ID: 30053818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the roles of Apolipoprotein E in adipocyte biology and obesity.
    Jiang CL; Lin FJ
    Int J Obes (Lond); 2024 Sep; 48(9):1205-1215. PubMed ID: 38839985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.
    Panera N; Della Corte C; Crudele A; Stronati L; Nobili V; Alisi A
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):393-403. PubMed ID: 26654761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisomes compensate hepatic lipid overflow in mice with fatty liver.
    Knebel B; Hartwig S; Haas J; Lehr S; Goeddeke S; Susanto F; Bohne L; Jacob S; Koellmer C; Nitzgen U; Müller-Wieland D; Kotzka J
    Biochim Biophys Acta; 2015 Jul; 1851(7):965-76. PubMed ID: 25790917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gut microbiota: obesity and NAFLD.
    Gangarapu V; Yıldız K; Ince AT; Baysal B
    Turk J Gastroenterol; 2014 Apr; 25(2):133-40. PubMed ID: 25003671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis.
    Silvestri C; Paris D; Martella A; Melck D; Guadagnino I; Cawthorne M; Motta A; Di Marzo V
    J Hepatol; 2015 Jun; 62(6):1382-90. PubMed ID: 25595882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipocyte-hepatocyte crosstalk in cellular models of obesity: Role of soluble factors.
    Baldini F; Diab F; Serale N; Zeaiter L; Portincasa P; Diaspro A; Vergani L
    Life Sci; 2023 Mar; 317():121464. PubMed ID: 36731646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific DNA methylation profiles regulate liver-specific expression of the APOA1/C3/A4/A5 cluster and can be manipulated with demethylating agents on intestinal cells.
    Guardiola M; Oliva I; Guillaumet A; Martín-Trujillo Á; Rosales R; Vallvé JC; Sabench F; Del Castillo D; Zaina S; Monk D; Ribalta J
    Atherosclerosis; 2014 Dec; 237(2):528-35. PubMed ID: 25463085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy: Emerging roles in lipid homeostasis and metabolic control.
    Christian P; Sacco J; Adeli K
    Biochim Biophys Acta; 2013 Apr; 1831(4):819-24. PubMed ID: 23274236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatosteatosis and estrogen increase apolipoprotein O production in the chicken.
    Schmidinger B; Weijler AM; Schneider WJ; Hermann M
    Biochimie; 2016 Aug; 127():37-43. PubMed ID: 27126072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin and PPAR: a setup for intricate crosstalk between obesity and non-alcoholic fatty liver disease.
    Ishtiaq SM; Rashid H; Hussain Z; Arshad MI; Khan JA
    Rev Endocr Metab Disord; 2019 Sep; 20(3):253-261. PubMed ID: 31656991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
    Jakel H; Nowak M; Helleboid-Chapman A; Fruchart-Najib J; Fruchart JC
    Ann Med; 2006; 38(1):2-10. PubMed ID: 16448983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism.
    Rodríguez A; Ezquerro S; Méndez-Giménez L; Becerril S; Frühbeck G
    Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E691-714. PubMed ID: 26330344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic role of exchangeable apolipoproteins in lipoprotein assembly and secretion.
    Sundaram M; Yao Z
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1073-8. PubMed ID: 22517365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.